Terkko Navigator / Multiple Sclerosis Journal – Experimental, Translational and Clinical

EMDR treatment for anxiety in MS patients: A pilot study

Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years

Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis

CD8+ T cell gene expression analysis identifies differentially expressed genes between multiple sclerosis patients and healthy controls

Physical activity monitoring to assess disability progression in multiple sclerosis

Brainstem lesions are associated with sleep apnea in multiple sclerosis

Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis

Functional evolution of visual involvement in experimental autoimmune encephalomyelitis

Laminar analysis of the cerebellar cortex shows widespread damage in early MS patients: A pilot study at 7T MRI

Cost-of-illness trajectories among people with multiple sclerosis by comorbidity: A register-based prospective study in Sweden

The impact of the face-to-face consultation on decisional conflict in complex decision-making in multiple sclerosis: A pilot study

The feasibility of assessing cognitive and motor function in multiple sclerosis patients using robotics

Effect of tobacco use on disease activity and DMT discontinuation in multiple sclerosis patients treated with dimethyl fumarate or fingolimod

Enlarged perivascular spaces are not associated with vascular co-morbidities, clinical outcomes, and brain volumes in people with secondary progressive multiple sclerosis

Long-term worsening of different body functions in persons with progressive multiple sclerosis

Familial aggregation of multiple sclerosis: Results from the national registry of the disease in Saudi Arabia

A comparative study of tolerability and effects on immunoglobulin levels and CD19 cell counts with ocrelizumab vs low dose of rituximab in multiple sclerosis

Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic

Environmental enrichment alleviates the deleterious effects of stress in experimental autoimmune encephalomyelitis

Importance of early treatment decisions on future income of multiple sclerosis patients

Anti-JCV antibody index does not change during ocrelizumab-treatment

Cannabinoid use among Americans with MS: Current trends and gaps in knowledge

Comparison of first-line and second-line use of fingolimod in relapsing MS: The open-label EARLIMS study

Sensorimotor function in progressive multiple sclerosis

Supplementary medication in multiple sclerosis: Real-world experience and potential interference with neurofilament light chain measurement

Prevalence of mental disorders is higher in patients with multiple sclerosis than in the general population or in patients with rheumatoid arthritis in France

Inner nuclear layer and olfactory threshold are interlinked and reflect inflammatory activity in multiple sclerosis

A feasibility study of a manualized resilience-based telehealth program for persons with multiple sclerosis and their support partners